173 related articles for article (PubMed ID: 12242076)
1. Distinctive response of thyroid-infiltrating mononuclear cells to B cell activation through CD40 and interleukin-4 in Graves' patients.
Itoh M; Uchimura K; Yamamoto K; Makino M; Imamura S; Kobayashi T; Fujiwara K; Kato T; Hayakawa N; Sawai Y; Nagasaka A; Iwase K; Nomura T; Hagino Y
Cytokine; 2002 Aug; 19(3):107-14. PubMed ID: 12242076
[TBL] [Abstract][Full Text] [Related]
2. The effects of CD40- and interleukin (IL-4)-activated CD23+ cells on the production of IL-10 by mononuclear cells in Graves' disease: the role of CD8+ cells.
Uchimura K; Itoh M; Yamamoto K; Imamura S; Makino M; Kato T; Fujiwara K; Sawai Y
Clin Exp Immunol; 2002 May; 128(2):308-12. PubMed ID: 11985521
[TBL] [Abstract][Full Text] [Related]
3. Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).
Itoh M; Uchimura K; Hayakawa N; Makino M; Hayashi R; Nagata M; Kakizawa H; Nagasaka A; Sakamoto H; Kuzuya H
Clin Exp Immunol; 1998 Aug; 113(2):309-14. PubMed ID: 9717983
[TBL] [Abstract][Full Text] [Related]
4. Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease.
Itoh M; Uchimura K; Makino M; Kobayashi T; Hayashi R; Nagata M; Kakizawa H; Fujiwara K; Nagasaka A
Cytokine; 2000 Jun; 12(6):688-93. PubMed ID: 10843746
[TBL] [Abstract][Full Text] [Related]
5. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
[TBL] [Abstract][Full Text] [Related]
6. Different immunophenotype and autoantibody production by peripheral blood and thyroid-derived lymphocytes in patients with Graves' disease.
Aust G; Lehmann I; Heberling HJ
Exp Clin Endocrinol Diabetes; 1996; 104(1):50-8. PubMed ID: 8750571
[TBL] [Abstract][Full Text] [Related]
7. IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency.
Punnonen J; Kainulainen L; Ruuskanen O; Nikoskelainen J; Arvilommi H
Scand J Immunol; 1997 Feb; 45(2):203-12. PubMed ID: 9042433
[TBL] [Abstract][Full Text] [Related]
8. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4.
Chomarat P; Briolay J; Banchereau J; Miossec P
Arthritis Rheum; 1993 Feb; 36(2):234-42. PubMed ID: 8431213
[TBL] [Abstract][Full Text] [Related]
9. Effect of interleukin-10 on anti-CD40- and interleukin-4-induced immunoglobulin E production by human lymphocytes.
Uejima Y; Takahashi K; Komoriya K; Kurozumi S; Ochs HD
Int Arch Allergy Immunol; 1996 Jul; 110(3):225-32. PubMed ID: 8688668
[TBL] [Abstract][Full Text] [Related]
10. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.
Bossowski A; Urban M; Stasiak-Barmuta A
J Pediatr Endocrinol Metab; 2003 Jan; 16(1):63-70. PubMed ID: 12585342
[TBL] [Abstract][Full Text] [Related]
11. Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells.
Goto Y; Itoh M; Ohta Y; Ogawa N; Goto Y; Ohashi H
Thyroid; 1997 Aug; 7(4):567-73. PubMed ID: 9292944
[TBL] [Abstract][Full Text] [Related]
12. Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease.
Balázs C; Bokk A; Farid NR
Thyroid; 1994; 4(1):27-30. PubMed ID: 8054859
[TBL] [Abstract][Full Text] [Related]
13. Fas/FasL mediated apoptosis of thyrocytes in Graves' disease.
Sera N; Kawakami A; Nakashima T; Nakamura H; Imaizumi M; Koji T; Abe Y; Usa T; Tominaga T; Ejima E; Ashizawa K; Yokoyama N; Ishikawa N; Ito K; Eguchi K
Clin Exp Immunol; 2001 May; 124(2):197-207. PubMed ID: 11422195
[TBL] [Abstract][Full Text] [Related]
14. Low frequency of IL-10-producing B cells and high density of ILC2s contribute to the pathological process in Graves' disease, which may be related to elevated-TRAb levels.
Ji X; Wan J; Chen R; Wang H; Huang L; Wang S; Su Z; Xu H
Autoimmunity; 2020 Mar; 53(2):78-85. PubMed ID: 31809586
[TBL] [Abstract][Full Text] [Related]
15. Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease.
Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Tezuka H; Nakao H; Kawakami A; Migita K; Ishikawa
J Clin Endocrinol Metab; 1989 Nov; 69(5):939-45. PubMed ID: 2793996
[TBL] [Abstract][Full Text] [Related]
16. Cytokine profiles of in vivo activated thyroid-infiltrating T cells cloned in the presence or absence of interleukin 4.
Guo J; Rapoport B; McLachlan SM
Autoimmunity; 1997; 26(2):103-10. PubMed ID: 9546811
[TBL] [Abstract][Full Text] [Related]
17. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
Chan JY; Walfish PG
Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
[TBL] [Abstract][Full Text] [Related]
18. [Costimulatory molecule CD40 expression in thyroid tissue of Graves' disease patients and its immune pathogenetic significance].
Wang FM; Chen XM; Hao C; Tang HB; Shen Q; Xu XY; Xu XG; Qian H; Li Q; Yao P; Li JH; Chen L
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(10):764-7. PubMed ID: 23755815
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production.
Scheffel F; Heine G; Henz BM; Worm M
Inflamm Res; 2005 Mar; 54(3):113-8. PubMed ID: 15883744
[TBL] [Abstract][Full Text] [Related]
20. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
